looking lost and dazed and confused during the ongoing nato summit that has taken place in lithuania. unfortunately the start of his trip was not much better either. yesterday he appeared to awkwardly use king charles for balance, hanging onto him and walk with a noticeable stiffness we will call it. later he seemed to forget where he was, distracted in conversation with a british soldier before having to be led away by king charles. move this way, mr. president. whatever. i can t do it. since becoming president joe s time in office has been nothing but one embarrassment after another. the economy is in shambles. world affairs could not be any worse than there. now joe also skipped out on tonight s dinner with other nato leaders sending secretary of state tony blinken in his place. that should give you all the confidence. according to officials he has a big speech tomorrow and a four day. week which is frankly too much for your week, frail, cognitive mess of a president to ha
symptoms are mild, he told americans keep the faith, it will be ok. the white house answering this question moments ago. if the president s oxygen level e martha: with that, we bring in dr. marty makary and management at johns hopkins. a person that we have turned to many times the past couple years. good to have you with us this afternoon. now that we heard from the white house, the press secretary, the doctor, a letter, a statement from the doctor who is treating the president, what do you think about this? i m optimistic about the prognosis. the president got the booster within four months. so he s had a sugar high from the booster dose. he s going to get added protection there. he s in the group that qualifies for the booster. if i were advising the president, i d re-assure the president, he s in a good situation. he has one covid risk factor, the advanced stage. so the prognosis is very good. so we have a list of some of the health situations the president has be
In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.